Mercury Laboratories Ltd.

858.10 ▼0%

25 April 2024, 04:01:00 PM

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.mercurylabs.com
Market Cap 102.97 Cr.
Enterprise Value(EV) 102.76 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 34.26 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 25.05 Trailing Twelve Months Ending 2023-12
Industry PE 41.74 Trailing Twelve Months Ending 2023-12
Book Value / Share 407.78 Trailing Twelve Months Ending 2023-12
Price to Book Value 2.10 Calculated using Price: 858.10
Dividend Yield 0.41 Period Ending 2023-03
No. of Shares Subscribed 0.12 Cr. 1,200,000 Shares
FaceValue 10
About Mercury Laboratories Ltd.
The company is engaged in manufacturing of pharmaceutical products. It is mainly dedicated to Mother and child care products.

Mercury Laboratories Ltd. Delivery

Delivered Qty
Traded Qty

Mercury Laboratories Ltd. Performance

1 Day
1 Week
-3.60%
1 Month
-0.92%
3 Month
-28.12%
6 Month
+8.46%
1 Year
+37.27%
2 Year
+67.60%
5 Year
+195.90%
10 Year

Mercury Laboratories Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 19.75 19.62 11.67 7.92 10.26 10.59 15.5 9.23 12.98
Return on Capital Employed (%) 21.32 21.58 18.93 9.89 13.77 13.25 20.56 12.26 16.29
Return on Assets (%) 8.01 8.81 5.54 3.92 5.2 5.68 8.77 5.57 8.58

Mercury Laboratories Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 18 22 24 26 29 32 37 40 46 48
Non Curr. Liab. 4 4 10 12 11 9 10 6 6 6
Curr. Liab. 21 20 17 13 17 15 19 16 16 21
Minority Int.
Equity & Liab. 43 47 51 52 57 56 65 62 68 75
Non Curr. Assets 20 19 20 22 25 25 28 27 26 27
Curr. Assets 23 28 31 30 32 32 38 35 42 48
Misc. Exp. not W/O
Total Assets 43 47 51 52 57 56 65 62 68 75

Mercury Laboratories Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 41 48 48 52 56 57 69 58 75 78
Other Income 1 1 0 0 1 1 1 1 2 1
Total Income 42 48 48 52 57 58 69 59 77 79
Total Expenditure -35 -41 -41 -47 -50 -51 -59 -51 -67 -70
PBIDT 7 7 7 5 7 7 10 8 10 9
Interest -1 -1 -1 -1 -1 -1 -1 0 0 0
Depreciation -1 -1 -1 -1 -2 -2 -2 -2 -2 -3
Taxation -1 -1 -2 0 -1 -1 -3 -1 -2 -1
Exceptional Items 0 0 0
PAT 3 4 3 2 3 3 5 4 6 4
Adjusted EPS 28 33 23 17 24 27 44 30 46 34

Mercury Laboratories Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 3 3 0 2 5 5 5 8 5 2
Cash Fr. Inv. -2 -2 0 -2 -4 -5 -1 -5 -2 -1
Cash Fr. Finan. -1 -2 0 0 1 -3 -3 -1 -1 -1
Net Change 0 0 0 0 2 -2 1 2 2 0
Cash & Cash Eqvt 1 1 1 1 4 1 3 5 7 7

Mercury Laboratories Ltd. Shareholding Pattern

9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 73.66 73.66 73.66 73.66 73.66 73.66 73.66 73.66 73.66
Public 26.34 26.34 26.34 26.34 26.34 26.34 26.34 26.34 26.34
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Mercury Laboratories Ltd. Announcements

Thu, 18 Apr 2024
Compliance Certificate Pursuant To Regulation 40(9) Of SEBI (LODR) Regulations 2015
Compliance Certificate pursuant to Regulation 40(9) of SEBI(LODR) Regulations 2015 for the financial year ended on March 31 2024
Wed, 10 Apr 2024
Compliance Certificate Pursuant To Reg 7(3) Of SEBI(LODR) Reg 2015 For The Period Ended On 31St March 2024
Compliance Certificate pursuant to Reg 7(3) of SEBI(LODR) Reg 2015 for the period ended on 31st March 2024
Mon, 08 Apr 2024
Announcement under Regulation 30 (LODR)-Change in Management
Intimation under Reg. 30 of SEBI(LODR) Regulations 2015 for Resignation of Mr. Mahendra Patel- General Manager Production

Mercury Laboratories Ltd. Technical Scans

Thu, 25 Apr 2024
High Decrease in 3 Months High Decrease in 3 Months
High Increase in 1 Year High Increase in 1 Year
High Increase in 2 Years High Increase in 2 Years
High Increase in 5 Years High Increase in 5 Years
20 SMA Crossing 50 SMA From Below 20 SMA Crossing 50 SMA From Below

Mercury Laboratories Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 364,830.88 1,511.25 -0.6%
Cipla Ltd. 113,471.29 1,409.35 +0.2%
Dr. Reddy's Laboratories Ltd. 103,713.42 6,247.50 +0.5%
Divi's Laboratories Ltd. 101,959.84 3,992.65 +3.9%
Zydus Lifesciences Ltd. 95,944.41 948.65 -0.3%
Mankind Pharma Ltd. 95,926.91 2,421.25 +1.0%
Apollo Hospitals Enterprise Ltd. 91,425.47 6,319.95 -1.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 40.96 1,511.25 -0.6%
Cipla Ltd. Consolidated 2023-12 30.60 1,409.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.84 6,247.50 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-12 73.73 3,992.65 +3.9%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.26 948.65 -0.3%
Mankind Pharma Ltd. Consolidated 2023-12 55.54 2,421.25 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 115.83 6,319.95 -1.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.85 1,511.25 -0.6%
Cipla Ltd. Consolidated 2023-12 4.38 1,409.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.86 6,247.50 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-12 7.82 3,992.65 +3.9%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.09 948.65 -0.3%
Mankind Pharma Ltd. Consolidated 2023-12 10.80 2,421.25 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.54 6,319.95 -1.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,511.25 -0.6%
Cipla Ltd. Consolidated 2023-03 0.02 1,409.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,247.50 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,992.65 +3.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 948.65 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,421.25 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,319.95 -1.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,511.25 -0.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,409.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,247.50 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,992.65 +3.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 948.65 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,421.25 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,319.95 -1.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,511.25 -0.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,409.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,247.50 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,992.65 +3.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 948.65 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,421.25 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,319.95 -1.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,511.25 -0.6%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,409.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,247.50 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,992.65 +3.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 948.65 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,421.25 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,319.95 -1.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,511.25 -0.6%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,409.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,247.50 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,992.65 +3.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 948.65 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,421.25 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,319.95 -1.0%

Mercury Laboratories Ltd. FAQ's

What is Mercury Laboratories share price?

Can I buy Mercury Laboratories shares now?

What is the Dividend Yield of Mercury Laboratories?

What is the Market Cap of Mercury Laboratories?

What are the key metrics to analyse Mercury Laboratories?

What is the 52 Week High and Low of Mercury Laboratories?